FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 143 filers reported holding FLEXION THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $15,787,000 | -26.3% | 2,588,032 | -0.6% | 0.00% | -100.0% |
Q2 2021 | $21,425,000 | -1.2% | 2,603,288 | +7.4% | 0.00% | 0.0% |
Q1 2021 | $21,695,000 | -20.7% | 2,424,017 | +2.2% | 0.00% | 0.0% |
Q4 2020 | $27,367,000 | +14.2% | 2,371,463 | +3.0% | 0.00% | 0.0% |
Q3 2020 | $23,962,000 | -19.9% | 2,301,875 | +1.2% | 0.00% | 0.0% |
Q2 2020 | $29,913,000 | +115.1% | 2,274,797 | +28.8% | 0.00% | 0.0% |
Q1 2020 | $13,905,000 | -62.1% | 1,766,819 | -0.4% | 0.00% | 0.0% |
Q4 2019 | $36,704,000 | +49.9% | 1,773,137 | -0.8% | 0.00% | 0.0% |
Q3 2019 | $24,487,000 | +5.9% | 1,786,748 | -4.9% | 0.00% | 0.0% |
Q2 2019 | $23,118,000 | +8.9% | 1,879,528 | +10.5% | 0.00% | 0.0% |
Q1 2019 | $21,234,000 | +14.6% | 1,701,488 | +4.0% | 0.00% | 0.0% |
Q4 2018 | $18,526,000 | -38.8% | 1,636,693 | +1.1% | 0.00% | 0.0% |
Q3 2018 | $30,294,000 | -26.8% | 1,619,112 | +1.1% | 0.00% | -50.0% |
Q2 2018 | $41,380,000 | +19.1% | 1,600,789 | +3.3% | 0.00% | 0.0% |
Q1 2018 | $34,740,000 | -4.9% | 1,550,207 | +6.3% | 0.00% | 0.0% |
Q4 2017 | $36,529,000 | +32.6% | 1,458,808 | +28.1% | 0.00% | +100.0% |
Q3 2017 | $27,539,000 | +29.2% | 1,138,934 | +8.0% | 0.00% | 0.0% |
Q2 2017 | $21,321,000 | -20.4% | 1,054,464 | +5.9% | 0.00% | 0.0% |
Q1 2017 | $26,784,000 | +46.3% | 995,321 | +3.4% | 0.00% | 0.0% |
Q4 2016 | $18,313,000 | +12.0% | 962,842 | +15.1% | 0.00% | 0.0% |
Q3 2016 | $16,346,000 | +56.9% | 836,557 | +20.2% | 0.00% | 0.0% |
Q2 2016 | $10,418,000 | +130.7% | 696,151 | +41.8% | 0.00% | – |
Q1 2016 | $4,515,000 | -47.5% | 490,824 | +9.9% | 0.00% | -100.0% |
Q4 2015 | $8,607,000 | -94.4% | 446,614 | -91.4% | 0.00% | -83.3% |
Q3 2015 | $154,809,000 | +1669.2% | 5,174,540 | +1194.5% | 0.01% | +500.0% |
Q2 2015 | $8,750,000 | +86.4% | 399,743 | +91.8% | 0.00% | – |
Q1 2015 | $4,693,000 | +84.4% | 208,370 | +65.3% | 0.00% | – |
Q4 2014 | $2,545,000 | +368.7% | 126,057 | +323.8% | 0.00% | – |
Q3 2014 | $543,000 | +95.3% | 29,742 | +44.4% | 0.00% | – |
Q2 2014 | $278,000 | – | 20,603 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |